
Insight
What is the next big innovation coming to the Life Sciences sector?
October 16th 2024
In our recent Life Sciences round table, Compass Carter Osborne welcomed a cohort of industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.
Addressing a broad range of topics, panelists addressed questions on biotech funding bounce-back; investment appetite in innovative technologies; quantum computing and AI; driving positive outcomes for the sector; and much more.
Key areas of discussion covered off:
- Which innovations might have the biggest positive impact on the sector in the next five years
- Investor standpoint: which technologies are you most likely to invest in, and why?
- Quantum Computing – hype or hope?
- What can the Life Sciences sector do to ensure the potential for innovation through computing is delivered?
- Biotech funding cycle bounce-back
- Therapeutic or devices in 2025 – target markets
Â
The CCO team extend their sincere thanks to the following participants:
- Geoff Dobson (Discussion Chair)
- Matthew Fyfe, Storm Therapeutics
- Prashant Shah, O2h Discovery
- Dr Iris Good, Plural
- Jerry Wu, TusPark Holdings
- Aline Charpentier, Bruntwood SciTech
- Sebastian Stachowiak, ICE Biopharma
- Colin Sims, Adthera Bio
- Dr Suhail Nurbhai, Mission Therapeutics
- Usman “Oz” Azam, Inspirna
- Stephen Dowd, Confo Therapeutics
- Tarquin Bennett-Coles, Compass Carter Osborne
- Martin Anderson, Carrot Recruitment
- Alex Boulger, Compass Carter Osborne